Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Novo Nordisk is doing just that, developing CagriSema, a medication that combines semaglutide with a novel drug known as cargrillintide
GBB is a pro-atherogenic intermediate in the conversion of L-carnitine to TMAO controlled by the gut microbiota (Koeth et al., 2014)
Kumar VV (2018) Aflatoxins: properties, toxicity and detoxification
This chapter explores the diseases associated with oxidative stress in melanocytes, highlighting their underlying mechanisms and clinical implications
Weve found that building a practice environment that supports thoughtful, collaborative decision-making is essential for navigating this complexity
US$ 22.86
US$ 22.69
US$ 24.17
US$ 21.37
US$ 23.97
US$ 24.33
